Latest Close
$20.08
News
JBIO
Jade Biosciences, Inc. News
This news view pulls recent coverage and headlines tied to JBIO.
1y Change
$11.80 (+142.51%)
Market Cap
$1.22B
Sector
Healthcare
Industry
Biotechnology
Recommendation
none
Jade Biosciences to Receive up to $22 Million as Part of Licensing Deal With Paragon Therapeutics
MT Newswires • Jul 2, 2026
Read articleIs Jade Biosciences, Inc. (JBIO) Stock a Rising Biotech Opportunity in the $20B IgA Nephropathy Market?
Insider Monkey • Jun 30, 2026
Read articleJade Biosciences Announces Appointment of Mark Eisner, M.D., M.P.H., to Board of Directors
GlobeNewswire • Jun 26, 2026
Read articleJade Biosciences Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
GlobeNewswire • Jun 5, 2026
Read articleJade Biosciences Announces Pricing of Public Offering of Common Stock
GlobeNewswire • Jun 4, 2026
Read articleJade Biosciences Announces Proposed Underwritten Public Offering
GlobeNewswire • Jun 3, 2026
Read article